In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent

Magnetic Resonance in Medicine

Volumn 52, Issue 6, 2004, Pages 1263-1271

  Jack Jr , Clifford R ^a,c   Garwood, Michael ^b   Wengenack, Thomas M ^c   Borowski, Bret ^a   Curran, Geoffrey L ^c   Lin, Joseph ^b   Adriany, Gregor ^b   Gröhn, Olli H J ^b,d   Grimm, Roger ^a   Poduslo, Joseph F ^c  

^a Mayo Clinic College of Medicine   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Alzheimer's disease; Magnetic resonance imaging; MR microscopy; Transgenic mice

Indexed keywords

GLYCOPROTEINS; MAMMALS; NEURODEGENERATIVE DISEASES; SPIN POLARIZATION; VISUALIZATION;

ADIABATIC PULSE; ALZHEIMER'S DISEASE; AMYLOID PLAQUES; CONTRAST RESOLUTION; GRADIENT ECHO SEQUENCES; HISTOLOGIC CORRELATIONS; MR MICROSCOPY; TRANSGENIC MICE;

MAGNETIC RESONANCE IMAGING;

AMYLOID; CONTRAST MEDIUM; IRON;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; EX VIVO STUDY; GENE EXPRESSION; IMAGE QUALITY; IN VIVO STUDY; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SENILE PLAQUE; TRANSGENIC MOUSE;

EID: 10044278300     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.20266     Document Type: Article

References (31)

1. Evans DA, Funkenstein HH, Albert MS. Prevalence of Alzheimer's disease in a community population of older persons. JAMA 1989;262:2551-2556.
2. McKhann G, Drachmen D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
3. Growdon JH. Biomarkers of Alzheimer disease. Arch Neurol 1999;56:281-283.
4. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002;297:353-356.
5. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin D, Yang F, Cole GM. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 1996;274:99-102.
6. Holcomb L, Gordon M, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin SG, Hsiao K, Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 1998;4:97-100.
7. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Liebergurg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999;400:173-177.
8. Klunk WE, Debnath ML, Pettegrew JW. Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probe. Neurobiol Aging 1998;16:541-548.
9. Klunk WE, Wang Y, Huang GF, Debnath ML, Holt DP, Shao L, Hamilton RL, Ikonomovic MD, DeKosky ST, Mathis CA. The binding of 2-(4′- methylaminophenyl) benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J Neurosci 2003;23(6):2086-2092.
10. Skovronsky DM, Zhang B, Kung M-P, Kung HF, Trojanowski JQ, Lee VM. In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2000;97(13):7609-7614.
11. Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P, Read S, Satyamurthy N, Petric A, Huang SC, Barrio JR. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry 2002;10:24-35.
12. Klunk WE, Engler H, Nordberg A, Wang Y, G B, P HD, Bergstrom M, I S, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004;55:306-319.
13. Bacskai BJ, Hickey GA, Skoch J, Kajdasz ST, Wang Y, Huang GF, Mathis CA, Khink WE, Hyman BT. Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice. Proc Natl Acad Sci USA 2003;100(21):12462-12467.
14. Beneviste H, Einstein G, Kim KR, Hulette C, Johnson GA. Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proc Natl Acad Sci USA 1999;96(24):14079-14084.
15. Poduslo JF, Wengenack TM, Curran GL, Wisniewski T, Sigurdsson EM, Macura SI, Borowski BJ, Jack CR, Jr. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol Dis 2002;11:315-329.
16. Dhenain M, Privat N, Duyckaerts C, Jacobs RE. Senile plaques do not induce susceptibility effects in T2*-weighted MR microscopic images. NMR Biomed 2002;15:197-203.
17. Wadghiri YZ, Sigurdsson EM, Sadowski M, Elliott JI, Li Y, Scholtzova H, Tang CY, Aguinaldo G, Pappolla M, Duff K, Wisniewski T, Turnbull DH. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magn Reson Med 2003;50:293-302.
18. Helpern JA, Lee S-P, Falangola MF, Dyakin V, Bogart A, Ardekani B, Duff K, Branch C, Wisniewski T, de Leon MJ, Wolf O, O'Shea J, Nixon RA. MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease. Magn Reson Med 2004;51:794-798.
19. Zhang J, Yarowsky P, Gordon MN, DiCarlo G, Munireddy S, van Zijl PCM, Mori S. Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging. Magn Reson Med 2004;51:452-457.
20. Wengenack TM, Whelan S, Curran GL, Duff KE, Poduslo JF. Quantitative histological analysis of amyloid deposition in Alzheimer's double transgenic mouse brain. Neuroscience 2000;101:939-944.
21. Grohn O, Poduslo JF, Jack CR Jr., Lin J, Garwood M. Adiabatic inner volume selection (IVS) method for high resolution 3D MRI. Proceedings of the 11th Annual Meeting of ISMRM, Toronto, Canada, 2003. p.11960.
22. Garwood M, Ke Y. Symmetric pulses to induce arbitrary flip angles with compensation for rf inhomogeneity and resonance offsets. J Magn Reson 1991;94:511-525.
23. Silver MS, Jospeh RI, Hoult DI. Highly selective π/2 and π pulse generation. J Magn Reson 1984;59:347-351.
24. Cassidy PJ, Schneider JE, Grieve SM, Lygate C, Neubauor S, Clarke K. Assessment of motion gating strategies for mouse magnetic resonance at high magnetic fields. J Magn Reson Imaging 2004;19:229-237.
25. Ugurbil K, Tseko NV, Garwood M. Fast MRI for assessment of myocardial perfusion with arrhythmia insensitive magnetization preparation. US Patent No. 5;908386:1999.
26. Ehman RL, Felmlee JP. Adaptive technique for high-definition MR imaging of moving structures. Radiology 1989;173:255-263.
27. Sheehan DC, Hrapchak BB. Theory and practice of histotechnology. Columbus, OH: Battelle Press; 1980. pp. 217-218.
28. Robb RA. A software sytem for interactive and quantitative analysis of biomedical images, In: Hohne KH, Fuchs H, Pizer SM, editors. 3D imaging in medicine. Berlin: Springer-Verlag; 1990. pp. 333-361.
29. Wengenack TM, Curran GL, Poduslo JF. Targeting Alzheimer amyloid plaques in vivo. Nat Biotechnol 2000;18:868-872.
30. Poduslo JF, Curran GL, Peterson JA, McCormick DJ, Fauq AH, Khan MA, Wengenack TM. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high bloodbrain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques. Biochemistry 2004;43:6064-6075.
31. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. Copper, iron, and zinc in Alzheimer's disease senile plaques. J Neurol Sci 1998;158:47-52.